Zhongzhi Pharm Hldg Ltd (3737) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Zhongzhi Pharm Hldg Ltd stock HK$0.78, price HK$0.66, upside +19.1%, quality 51 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Zhongzhi Pharm Hldg Ltd
3737 · HKSolid company and rising price, but only slightly cheap (16% below fair value): meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 13, 2026.
How to read this chart
60‑month range HK$0.5200 – HK$1.38 · fair‑value band HK$0.7500 – HK$0.8400 · the HK$0.6550 price screens below the HK$0.7800 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 13, 2026.
Every Wednesday you see whether Zhongzhi Pharm Hldg is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China.
Show moreShow less
The company operates through two segments Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names.
In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing and property management. Further, the company engages in the wholesale of pharmaceutical products; and provision of traditional Chinese medicine service.
Zhongzhi Pharmaceutical Holdings Limited was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited operates as a subsidiary of Crystal Talent Investment Group Limited.
Stock analysis
Zhongzhi Pharm Hldg Ltd (3737) currently trades at HK$0.6550, while our model-based Fair Value estimate is HK$0.7800, implying the stock looks roughly 16% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of HK$1.19 per share, and 11 of the 26 models we run sit above the HK$0.6550 price.
Bear case: the Earnings-Based group reads lowest at HK$0.3100, and 15 of the 26 models stay below the price. Data coverage for this calculation is low.
Scenario range: HK$0.7500 (bear) to HK$0.8400 (bull), the price of HK$0.6550 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 51/100 (solid quality), in the Healthcare sector.
Weak Growth: Growth has flattened: the last year, three and five years all grew more slowly than the long-term average.
Zhongzhi Pharm Hldg Ltd reported revenue of HK$1.7B in FY2025 versus HK$1.7B in FY2021, a compound −0.1%/yr. Reported net income was HK$17.3M in FY2025, compounding −24.1%/yr from FY2021.
Key figures
Market cap HK$553M (≈ $70.4M) Micro · P/E ratio 30.5 · P/S ratio 0.30 · Dividend yield 7.3% · Net margin 1.1% · Return on equity 1.6% · Return on assets (EBIT) 5.5% (5-year average) · Operating margin 0.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (low confidence).
What moves the price
The share trades about 28% below its 52-week high and 26% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 19%, 3737 screens cheaper than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch 3737, get fair value alerts →
Compare Zhongzhi Pharm Hldg Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 605 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Consumer Staples sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Fair value gap by industry
- Return on assets by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Hong Kong Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs 3737 |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.07 | ¥53.04 | +10% | vs 3737 |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,880 | ₹1,983 | +5% | vs 3737 |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs 3737 |
| Merck KGaA MRK | €149.60 | €108.83 | −27% | vs 3737 |
| Galderma Group GALD | CHF 191.40 | CHF 112.30 | −41% | vs 3737 |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs 3737 |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs 3737 |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs 3737 |
| Divi's Laboratories Limited DIVISLAB | ₹11,442 | ₹1,567 | −86% | vs 3737 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Zhongzhi Pharm Hldg Ltd (3737) overvalued or undervalued?
What is the fair value of 3737?
What is the quality score of 3737?
What is the price target for Zhongzhi Pharm Hldg Ltd (3737)?
What is the Zhongzhi Pharm Hldg Ltd stock forecast for 2026?
What is the revenue of Zhongzhi Pharm Hldg Ltd (3737)?
Does Zhongzhi Pharm Hldg Ltd pay a dividend?
How much is the dividend of Zhongzhi Pharm Hldg Ltd (3737)?
What growth is priced into Zhongzhi Pharm Hldg Ltd (3737)?
What discount rate (WACC) does the fair value of 3737 use?
What is a reverse DCF?
How much growth has Zhongzhi Pharm Hldg Ltd (3737) delivered so far?
How fast is the sector of Zhongzhi Pharm Hldg Ltd (3737) growing?
What is the free cash flow yield of Zhongzhi Pharm Hldg Ltd (3737)?
What is the intrinsic value of Zhongzhi Pharm Hldg Ltd (3737)?
Is Zhongzhi Pharm Hldg Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 3737?
How much is Zhongzhi Pharm Hldg Ltd worth?
What do the bullish and bearish scenarios say about 3737?
What is the P/E ratio of 3737?
How solid is the balance sheet of Zhongzhi Pharm Hldg Ltd (3737)?
How far is 3737 from its 52-week high?
Which stocks are comparable to Zhongzhi Pharm Hldg Ltd?
Is Zhongzhi Pharm Hldg Ltd stock attractive at the current price?
How is the fair value of 3737 calculated?
Is it still worth investing in stocks now?
What is the share price of Zhongzhi Pharm Hldg Ltd (3737)?
What should I pay attention to with Zhongzhi Pharm Hldg Ltd right now?
Where does the earnings growth of Zhongzhi Pharm Hldg Ltd (3737) come from?
Key figures of Zhongzhi Pharm Hldg Ltd
How large is the market capitalisation of Zhongzhi Pharm Hldg Ltd (3737)?
What is the P/S ratio of Zhongzhi Pharm Hldg Ltd (3737)?
What is the dividend yield of Zhongzhi Pharm Hldg Ltd (3737)?
What is the net margin of Zhongzhi Pharm Hldg Ltd (3737)?
What is the return on equity of Zhongzhi Pharm Hldg Ltd (3737)?
What is the EBIT return on assets of Zhongzhi Pharm Hldg Ltd (3737)?
What is the operating margin of Zhongzhi Pharm Hldg Ltd (3737)?
How fast is revenue growing at Zhongzhi Pharm Hldg Ltd (3737)?
How fast are earnings growing at Zhongzhi Pharm Hldg Ltd (3737)?
How much net debt does Zhongzhi Pharm Hldg Ltd (3737) carry?
Watch Zhongzhi Pharm Hldg Ltd in the live analysis
One click puts Zhongzhi Pharm Hldg Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.